After more than eight years at the helm of US biotech Scholar Rock, Nagesh Mahanthappa is standing down as CEO, to be replaced by biopharma industry veteran Tony Kingsley. Mahanthappa will stay on as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results